License & Collaborative Revenue was Protagonist Therapeutics’s largest product and service line in fiscal 2020, bringing in $27.10M of $28.60M (95%).
| Product and Service | FY 2020 |
|---|---|
| License & Collaborative Revenue | $27.10M |
| Additional Services | $1.50M |
| Total | $28.60M |
Protagonist Therapeutics brought in $28.60M from its two product and service lines in fiscal 2020, the year ended December 31, 2020. License & Collaborative Revenue was the largest at $27.10M (94.8%), ahead of Additional Services at $1.50M (5.2%).
License & Collaboration Agreement was Protagonist Therapeutics’s largest revenue line in fiscal 2018, bringing in $30.80M of $30.90M (100%).
| Type of Arrangement and Non-arrangement Transactions | FY 2018 |
|---|---|
| License & Collaboration Agreement | $30.80M |
| Phase 2 Clinical Trial | $100.00K |
| Total | $30.90M |
Protagonist Therapeutics brought in $30.90M from its two revenue lines in fiscal 2018, the year ended December 31, 2018. License & Collaboration Agreement was the largest at $30.80M (99.7%), ahead of Phase 2 Clinical Trial at $100.00K (0.3%).
Protagonist Therapeutics (PTGX) reports its revenue by product and service and by type of arrangement and non-arrangement transactions. In fiscal 2020, License & Collaborative Revenue was its largest product and service line, bringing in $27.10M (94.8% of the total), followed by Additional Services at $1.50M (5.2%).
License & Collaborative Revenue was Protagonist Therapeutics' largest product and service line in fiscal 2020, bringing in $27.10M, or 94.8% of the $28.60M total across its two product and service lines.
License & Collaboration Agreement was Protagonist Therapeutics' largest revenue line in fiscal 2018, bringing in $30.80M, or 99.7% of the $30.90M total across its two revenue lines.
Every figure comes from Protagonist Therapeutics' annual financial filings, as reported. Each line keeps the name Protagonist Therapeutics gives it, and years follow its fiscal calendar.
Protagonist Therapeutics' revenue by product and service goes back to fiscal 2020, with figures through fiscal 2020. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.